0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Nyaguara A/Wellcome Open Res
4 results

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.Hamaluba M Sang S Orindi B Njau I Karanja H Kamau N Gitonga JN Mugo D Wright D Nyagwange J Kutima B Omuoyo D Mwatasa M Ngetsa C Agoti C Cheruiyot S Nyaguara A Munene M Mturi N Oloo E Ochola-Oyier L Mumba N Mauncho C Namayi R Davies A Tsofa B Nduati EW Aliyan N Kasera K Etyang A Boyd A Hill A Gilbert S Douglas A Pollard A Bejon P Lambe T Warimwe G COVVaccine Trial Group
Wellcome Open Res, (2023). 8:182

Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya.Nyiro JU Bukusi E Mwaengo D Nyaguara A Nyawanda B Otieno N Bigogo G Murunga N Widdowson MA Verani JR Chaves SS Mwangudza H Odundo C Berkley JA Nokes DJ Munywoki PK
Wellcome Open Res, (2022). 7:43

Mortality in rural coastal Kenya measured using the Kilifi Health and Demographic Surveillance System: a 16-year descriptive analysis.Otiende M Bauni E Nyaguara A Amadi D Nyundo C Tsory E Walumbe D Kinuthia M Kihuha N Kahindi M Nyutu G Moisi J Deribew A Agweyu A Marsh K Tsofa B Bejon P Bottomley C Williams TN Scott JAG
Wellcome Open Res, (2021). 6:327

Mortality during and following hospital admission among school-aged children: a cohort study.Ngari MM Obiero C Mwangome MK Nyaguara A Mturi N Murunga S Otiende M Iversen PO Fegan GW Walson JL Berkley JA
Wellcome Open Res, (2020). 5:234